SMARCB1-negative tumors undoubtedly characterize hepatic rhabdoid tumors and unveil features similar to those of rhabdoid tumors, such as higher stage at diagnosis, chromosomal deletions or translocations of 22q11, and low serum AFP levels. This evidence concerns the gene AFP and rhabdoid tumor.